Cerebral abscess in a multiple sclerosis patient during treatment with natalizumab

被引：0
|
作者：
B. Durmus
J. Van Goethem
A. Vercruyssen
G. De la Meilleure
C. Jadoul
B. Willekens
机构：
[1] AZ Nikolaas,Department of Neurology
[2] AZ Nikolaas,Department of Radiology
[3] Moerlandstraat 1,Department of Neurology
[4] 9100,Laboratory of Experimental Hematology
[5] Department of Radiology,undefined
[6] Antwerp University Hospital,undefined
[7] Antwerp University Hospital,undefined
[8] University of Antwerp,undefined
来源：
Acta Neurologica Belgica | 2020年 / 120卷
关键词：
Natalizumab; Abscess; Bacterial infection; Multiple sclerosis; Immune system;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：215 / 217
页数：2
相关论文
共 50 条
  • [41] SEVERE ANEMIA IN A PATIENT WITH MULTIPLE SCLEROSIS TREATED WITH NATALIZUMAB
    Simone, Anna Maria
    Ferraro, Diana
    Vitetta, Francesca
    Marasca, Roberto
    Bonacorsi, Goretta
    Pinelli, Giovanni
    Federzoni, Lucia
    Nichelli, Paolo Frigio
    Sola, Patrizia
    NEUROLOGY, 2014, 83 (04) : 374 - 375
  • [42] Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
    O'Connor, P. W.
    Goodman, A.
    Kappos, L.
    Lublin, F. D.
    Miller, D. H.
    Polman, C.
    Rudick, R. A.
    Aschenbach, W.
    Lucas, N.
    NEUROLOGY, 2011, 76 (22) : 1858 - 1865
  • [43] Why patients with multiple sclerosis perceive improvement of gait during treatment with natalizumab?
    Klara Novotna
    Jan Rusz
    Eva Kubala Havrdova
    Jana Lizrova Preiningerova
    Journal of Neural Transmission, 2019, 126 : 731 - 737
  • [44] Treatment with natalizumab during the Covid-19 pandemic in multiple sclerosis patients
    Diaz-Diaz, Judit
    Isabel Ramirez, Clara
    Ortiz-Pica, Marta
    Garcia-Yusta, Elena
    Gomez-Estevez, Irene
    Oreja-Guevara, Celia
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [45] Increase of serum uric acid levels in multiple sclerosis during treatment with natalizumab
    Handouk, Yasmin
    Angeleri, Vita A.
    Danni, Maura
    De Riso, Stella
    Provinciali, Leandro
    MULTIPLE SCLEROSIS, 2008, 14 : S281 - S281
  • [46] Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis
    Petersen, Eva Rosa
    Sondergaard, Helle Bach
    Laursen, Julie Hejgaard
    Olsson, Anna Gabriella
    Boernsen, Lars
    Sorensen, Per Soelberg
    Sellebjerg, Finn
    Oturai, Annette Bang
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (09) : 1298 - 1305
  • [47] Why patients with multiple sclerosis perceive improvement of gait during treatment with natalizumab?
    Novotna, Klara
    Rusz, Jan
    Havrdova, Eva Kubala
    Preiningerova, Jana Lizrova
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (06) : 731 - 737
  • [48] An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations
    Kornek, Barbara
    PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 675 - 684
  • [49] NATALIZUMAB IN MULTIPLE SCLEROSIS
    Rio-Izquierdo, J.
    Montalban, X.
    REVISTA DE NEUROLOGIA, 2009, 49 (05) : 265 - 269
  • [50] Evolution of Nevi During Treatment With Natalizumab A Prospective Follow-up of Patients Treated With Natalizumab for Multiple Sclerosis
    Castela, Emeline
    Lebrun-Frenay, Christine
    Laffon, Muriel
    Rocher, Fanny
    Cohen, Michael
    Leccia, Nathalie Cardot
    Bahadoran, Philippe
    Lacour, Jean-Philippe
    Ortonne, Jean-Paul
    Passeron, Thierry
    ARCHIVES OF DERMATOLOGY, 2011, 147 (01) : 72 - 76
12345